AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $32,651,000 | +53.6% | 938,243 | +8.1% | 0.01% | +66.7% |
Q3 2016 | $21,264,000 | -1.6% | 867,546 | -3.9% | 0.00% | -25.0% |
Q2 2016 | $21,602,000 | +2.4% | 903,089 | +0.2% | 0.00% | +33.3% |
Q1 2016 | $21,094,000 | +2.0% | 901,438 | +31.6% | 0.00% | 0.0% |
Q4 2015 | $20,678,000 | -10.6% | 684,924 | +17.7% | 0.00% | -25.0% |
Q3 2015 | $23,129,000 | -42.5% | 582,166 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $40,204,000 | +18.8% | 582,166 | -6.0% | 0.01% | +20.0% |
Q1 2015 | $33,842,000 | +27.2% | 619,142 | -0.8% | 0.01% | +25.0% |
Q4 2014 | $26,614,000 | +23.5% | 624,440 | -7.6% | 0.00% | 0.0% |
Q3 2014 | $21,554,000 | +24.5% | 675,454 | -19.1% | 0.00% | +33.3% |
Q2 2014 | $17,307,000 | +4.8% | 835,271 | -2.1% | 0.00% | 0.0% |
Q1 2014 | $16,511,000 | -48.8% | 853,296 | -35.7% | 0.00% | -50.0% |
Q4 2013 | $32,237,000 | +121.5% | 1,327,708 | +95.9% | 0.01% | +100.0% |
Q3 2013 | $14,557,000 | -5.1% | 677,879 | -1.7% | 0.00% | 0.0% |
Q2 2013 | $15,345,000 | – | 689,660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |